These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24122851)

  • 1. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
    Gerlinger M; Quezada SA; Peggs KS; Furness AJ; Fisher R; Marafioti T; Shende VH; McGranahan N; Rowan AJ; Hazell S; Hamm D; Robins HS; Pickering L; Gore M; Nicol DL; Larkin J; Swanton C
    J Pathol; 2013 Dec; 231(4):424-32. PubMed ID: 24122851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.
    Zhang Q; Jia Q; Deng T; Song B; Li L
    Biochem Biophys Res Commun; 2015 Feb; 458(1):70-6. PubMed ID: 25637538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.
    Emerson RO; Sherwood AM; Rieder MJ; Guenthoer J; Williamson DW; Carlson CS; Drescher CW; Tewari M; Bielas JH; Robins HS
    J Pathol; 2013 Dec; 231(4):433-440. PubMed ID: 24027095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.
    Chen Z; Zhang C; Pan Y; Xu R; Xu C; Chen Z; Lu Z; Ke Y
    J Pathol; 2016 Aug; 239(4):450-8. PubMed ID: 27171315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma.
    Guo L; Bi X; Li Y; Wen L; Zhang W; Jiang W; Ma J; Feng L; Zhang K; Shou J
    J Pathol; 2020 May; 251(1):26-37. PubMed ID: 32073142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
    Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
    Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
    Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
    Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel evolution of tumour subclones mimics diversity between tumours.
    Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
    J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.
    Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A
    Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
    Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
    Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.
    Nakanishi K; Kukita Y; Segawa H; Inoue N; Ohue M; Kato K
    Cancer Med; 2016 Sep; 5(9):2513-21. PubMed ID: 27465739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene families.
    Sensi M; Castelli C; Anichini A; Grossberger D; Mazzocchi A; Mortarini R; Parmiani G
    Melanoma Res; 1991; 1(4):261-71. PubMed ID: 1668534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.
    Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD
    Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.
    Miyai M; Eikawa S; Hosoi A; Iino T; Matsushita H; Isobe M; Uenaka A; Udono H; Nakajima J; Nakayama E; Kakimi K
    PLoS One; 2015; 10(8):e0136086. PubMed ID: 26291626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy.
    Bai D; Feng H; Yang J; Yin A; Qian A; Sugiyama H
    Cancer Sci; 2021 Jun; 112(6):2126-2139. PubMed ID: 33735492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
    Yazdi AS; Morstedt K; Puchta U; Ghoreschi K; Flaig MJ; Rocken M; Sander CA
    J Invest Dermatol; 2006 Feb; 126(2):393-8. PubMed ID: 16374454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
    Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
    Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.